Please help us continue to improve nanoHUB operation and service by completing our survey - http://bit.ly/nH-survey14. Thank you - we appreciate your time. close

Support

Support Options

Submit a Support Ticket

 

Tags: nanomedicine

Description

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials. More information on Nanomedicine can be found here.

Resources (1-20 of 157)

  1. [Illinois] Translational Nanomedicine in the Interface of Chemistry, Biology, and Engineering

    26 Aug 2014 | Online Presentations | Contributor(s): Dipanjan Pan

    Prof. Pan joined University of Illinois in fall 2013. Previously, He was an Assistant Professor of Medicine, Research at the Division of Cardiology, Washington University in St. Louis. He also...

    http://nanohub.org/resources/21466

  2. [Illinois] Plasmonic Engineering in Nanomedicine

    28 Apr 2014 | Online Presentations | Contributor(s): Srikanth Singamaneni

    Plasmonics involves the control of light at the nanoscale using surface plasmons. One particular area where plasmonics is expected to make an enoromous impact is the field of life sciences, with...

    http://nanohub.org/resources/20927

  3. Application of Dynamic Light Scattering in the Physicochemical Characterization of Natural and Engineered Nanoparticles

    20 Apr 2012 | Online Presentations | Contributor(s): Trisha Eustaquio

    This presentation will highlight the use of dynamic light scattering (DLS), which measures the hydrodynamic size of nanoparticles in suspension, in characterizing specific examples of engineered...

    http://nanohub.org/resources/13637

  4. The Importance of Zeta Potential for Drug/Gene Delivery in Nanomedicine

    11 Apr 2012 | Online Presentations | Contributor(s): James Leary

    Keynote Address

    http://nanohub.org/resources/13630

  5. Finding a Needle in a Haystack: Nanobarcoding for Single Nanoparticle Detection in in vitro and ex vivo Nanomedical Biodistribution Studies

    14 Feb 2012 | Online Presentations | Contributor(s): Trisha Eustaquio

    Determination of the fate of administered nanoparticles in a biological system, or nanoparticle biodistribution, is critical in evaluating a nanoparticle formulation for nanomedical purposes....

    http://nanohub.org/resources/12665

  6. Illinois Nano EP Seminar Series Spring 2011: Interfacing Engineering, Biology, and Medicine at the Micro and Nano Scale

    13 Dec 2011 | Online Presentations | Contributor(s): Rashid Bashir

    In this talk, we will present an overview of our work in Silicon-Based BioMEMS and Bionanotechnology and discuss the state of the art and the future challenges and opportunities. We will review...

    http://nanohub.org/resources/12403

  7. KIST/PU Nanostructured Heparin Derivatives as an Angiogenesis Inhibitor

    07 Dec 2011 | Online Presentations | Contributor(s): Youngro Byun

    Although low molecular weight heparin (LMWH) has been known to regulate angiogenesis, tumor growth and metastasis, the administration of heparin for treating cancer is limited in clinical...

    http://nanohub.org/resources/12651

  8. KIST/PU The Professor’s Challenge: To commercialize or not, that is the question?

    06 Dec 2011 | Online Presentations | Contributor(s): J. Paul Robinson

    Outline: Outline the Professors Dilemma Show what the normal criteria for research project direction is Discuss the Corporate perspective Discuss an example of failed innovation Demonstrate...

    http://nanohub.org/resources/12652

  9. KIST/PU Designing a Research Program Around Unmet Clinical Needs

    06 Dec 2011 | Online Presentations | Contributor(s): Alyssa Panitch

    Dr. Panitch specializes in bioorganic chemistry, controlled release and materials and peptide therapeutics. Her research interests include the design and synthesis of biomaterials for drug...

    http://nanohub.org/resources/12650

  10. KIST/PU Theragnosis – A New Paradigm of Personalized Medicine

    06 Dec 2011 | Online Presentations | Contributor(s): Ick Chan Kwon

    Companion Diagnosis, based on pharmacogenomics, has been recognized as one of most important key representatives of personalized medicine. However, Companion Diagnosis does not provide any clues...

    http://nanohub.org/resources/12649

  11. Illinois BioNanotechnology Seminar Series Fall 2011: Precisely Size Controlled Drug-silica Nanoconjugate for Cancer Therapy

    05 Dec 2011 | Online Presentations | Contributor(s): Li Tang

    Drug delivery nanomedicine, exemplified by micelles and nanoparticles roughly in the size range of 1-200 nm, have attracted much interest in the past 2-3 decades as alternative modalities for...

    http://nanohub.org/resources/12440

  12. Illinois BioNanotechnology Seminar Series Fall 2011: Directed Blood Vessel Growth Using an Angiogenic Microfiber/Microparticle Composite Patch

    05 Dec 2011 | Online Presentations | Contributor(s): Ross J DeVolder

    Therapeutic angiogenesis has emerged as a promising strategy to treat various acute and chronic vascular diseases, and to enhance tissue repair and regeneration. Common revascularization therapies...

    http://nanohub.org/resources/12443

  13. Illinois BioNanotechnology Seminar Series Fall 2011: Deconvolving Stiffness in MEMS Pedestal Cell Mass Measurements

    05 Dec 2011 | Online Presentations | Contributor(s): Elise Corbin

    The complex relationships between a cell's behavior and the physical properties of both itself and its environment have long been of interest. Specifically, the understanding the mechanisms...

    http://nanohub.org/resources/12445

  14. BME 695L Special Lecture 4: Atomic Force Microscopy (AFM) for Nanomedical Systems (cells and nanoparticles)

    02 Dec 2011 | Online Presentations | Contributor(s): Helen McNally

    Guest lecturer: Helen McNally

    http://nanohub.org/resources/12625

  15. BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention

    02 Dec 2011 | Online Presentations | Contributor(s): Deborah W Knapp

    Guest lecturer: Deborah Knapp.

    http://nanohub.org/resources/12622

  16. BME 695L Lecture 15: GMP and Issues of Quality Control Manufacture of Nanodelivery Systems

    02 Dec 2011 | Online Presentations | Contributor(s): James Leary

    See references below for related reading. 15.1      Overview 15.1.1    What does cGMP mean? 15.1.2    Why GMP?...

    http://nanohub.org/resources/12497

  17. BME 695L Lecture 16: FDA and EPA Regulatory Issues

    02 Dec 2011 | Online Presentations | Contributor(s): James Leary

    See references below for related reading. 16.1      Introduction and overview 16.1.1    How does the FDA think about nanomedical...

    http://nanohub.org/resources/12498

  18. BME 695L Lecture 12: Assessing Drug Efficacy and Nanotoxicity at the Single Cell Level

    22 Nov 2011 | Online Presentations | Contributor(s): James Leary

    See references below for related reading. 12.1      Introduction to measures of efficacy for nanomedicine 12.1.1    for evaluation...

    http://nanohub.org/resources/12392

  19. BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use

    22 Nov 2011 | Online Presentations | Contributor(s): James Leary

    See references below for related reading. 13.1      Bringing in-vivo considerations into NMS design 13.1.1    the in-vitro to ex-vivo to...

    http://nanohub.org/resources/12495

  20. BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems

    22 Nov 2011 | Online Presentations | Contributor(s): James Leary

    See references below for related reading. 14.1      Introduction to integrated designs 14.1.1    “Total design” but there is some order in...

    http://nanohub.org/resources/12496

nanoHUB.org, a resource for nanoscience and nanotechnology, is supported by the National Science Foundation and other funding agencies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.